Maintaining the value of influenza vaccination – the shift from quadrivalent to trivalent vaccines: an expert review
Introduction This review provides an expert perspective on the sustained value of seasonal influenza vaccines as they transition from quadrivalent to trivalent formulations, based on apparent elimination of the B/Yamagata strain from circulation and subsequent advice from the World Health Organizati...
Saved in:
| Main Authors: | David Fisman, Alberto Pérez-Rubio, Maarten Postma, Darvin S. Smith, Joaquin Mould-Quevedo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2515597 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01) -
Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America
by: David Fisman, et al.
Published: (2024-12-01) -
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses
by: David Fisman, et al.
Published: (2024-12-01) -
Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
by: Eliel Nham, et al.
Published: (2023-12-01) -
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children
by: Stephanie A. Davey, et al.
Published: (2025-12-01)